Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma

被引:51
|
作者
Huhta, Heikki [1 ,2 ,4 ,5 ]
Helminen, Olli [1 ,2 ,4 ,5 ]
Lehenkari, Petri P. [2 ,3 ,4 ,5 ]
Saarnio, Juha [2 ,4 ,5 ]
Karttunen, Tuomo J. [1 ,4 ,5 ]
Kauppila, Joonas H. [1 ,2 ,4 ,5 ]
机构
[1] Univ Oulu, Dept Pathol, Oulu 90014, Finland
[2] Univ Oulu, Dept Surg, Oulu 90014, Finland
[3] Univ Oulu, Dept Anat & Cell Biol, Oulu 90014, Finland
[4] Med Res Ctr Oulu, Oulu 90014, Finland
[5] Oulu Univ Hosp, Oulu 90029, Finland
关键词
toll-like receptor 1; toll-like receptor 2; toll-like receptor 4; toll-like receptor 6; esophageal adenocarcinoma; EXPRESSION; TLR4; GROWTH;
D O I
10.18632/oncotarget.8151
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Toll-like receptors (TLRs) recognize microbial and endogenous ligands and have already shown to play a role in esophageal cancer. In this study, we evaluated especially TLRs that sense bacterial cell wall components in Barrett's esophagus, dysplasia and esophageal adenocarcinoma. Methods: TLRs 1, 2, 4 and 6 were stained immunohistochemically and assessed in esophageal specimens from patients with esophageal dysplasia (n = 30) or adenocarcinoma (n = 99). Structures and lesions were evaluated including normal esophagus (n = 88), gastric (n = 67) or intestinal metaplasia (n = 51) without dysplasia, and low-grade (n= 42) or high-grade dysplasia (n = 37), and esophageal adenocarcinoma (n = 99). Results: We found TLR1, TLR2, TLR4 and TLR6 expression in all lesions. TLR expression increased in Barrett's mucosa and dysplasia. There was profound increase of TLR expression from gastric-to intestinal-type columnar epithelium. In cancers, high nuclear and cytoplasmic staining of TLR4 associated with metastatic disease and poor prognosis. Conclusions: TLR1, TLR2, TLR4 and TLR6 are upregulated during malignant changes of esophageal columnar epithelium. Increased TLR4 expression associates with advanced stage and poor prognosis in esophageal adenocarcinoma.
引用
收藏
页码:23658 / 23667
页数:10
相关论文
共 50 条
  • [21] Toll-Like Receptor 2 Enhanced Lysosomal Activity and Endocytosis in a Barrett's Esophagus Cell Line
    Verbeek, Romy
    Siersema, Peter D.
    de Haan, Judith J.
    ten Kate, Fiebo
    Posthuma, George
    Souza, Rhonda F.
    Vleggaar, Frank P.
    van Baal, Jantine W.
    GASTROENTEROLOGY, 2015, 148 (04) : S347 - S347
  • [22] DCAMKL-1 Expression in Barrett's Esophagus and Esophageal Adenocarcinoma
    Whorton, Josh
    Lightfoot, Stanley
    Sureban, Sripathi M.
    May, Randal
    Qu, Dongfeng
    Madhoun, Mohammad
    Tierney, William M.
    Maple, John T.
    Vega, Kenneth.
    Houchen, Courtney W.
    GASTROENTEROLOGY, 2011, 140 (05) : S308 - S308
  • [23] Toll-like receptors 1, 2, 4 and 6 expression levels in diffusely infiltrative astrocytomas
    Moretti, Isabele F.
    Franco, Daiane Gil
    Silva, Roseli
    Galatro, Thais F.
    Oba-Shinjo, Sueli M.
    Marie, Suely K. N.
    CANCER RESEARCH, 2016, 76
  • [24] The influence of Toll-like receptors (1, 2, 4 and 6) on Leishmania mexicana infection of mice
    Halliday, A.
    Bates, P.
    Taylor, M.
    IMMUNOLOGY, 2010, 131 : 62 - 62
  • [25] Tenascin-C and fibronectin in normal esophageal mucosa, Barrett's esophagus, dysplasia and adenocarcinoma
    Leppanen, Joni
    Bogdanoff, Sara
    Lehenkari, Petri P.
    Saarnio, Juha
    Kauppila, Joonas H.
    Karttunen, Tuomo J.
    Huhta, Heikki
    Helminen, Olli
    ONCOTARGET, 2017, 8 (40) : 66865 - 66877
  • [26] Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma
    Wani, Sachin
    Falk, Gary
    Hall, Matthew
    Gaddam, Srinivas
    Wang, Amy
    Gupta, Neil
    Singh, Mandeep
    Singh, Vikas
    Chuang, Keng-Yu
    Boolchand, Vikram
    Gavini, Hemanth
    Kuczynski, John
    Sud, Priti
    Reddymasu, Savio
    Bansal, Ajay
    Rastogi, Amit
    Mathur, Sharad C.
    Young, Patrick
    Cash, Brooks
    Lieberman, David A.
    Sampliner, Richard E.
    Sharma, Prateek
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (03) : 220 - U61
  • [27] Endoscopic Resection for Barrett's Esophagus with High-Grade Dysplasia or Early Esophageal Adenocarcinoma
    Watson, Thomas J.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (04) : 310 - 319
  • [28] Circulating miRNAs in patients with Barrett's esophagus, high-grade dysplasia and esophageal adenocarcinoma
    Pavlov, Kirill
    Kluiver, Joost
    Meijer, Coby
    Boersma-van Ek, Wytske
    Kruyt, Frank A. E.
    Karrenbeld, Arend
    Kleibeuker, Jan H.
    Peters, Frans T. M.
    van den Berg, Anke
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (06) : 1150 - +
  • [29] Subsquamous Esophageal Adenocarcinoma after Radiofrequency Ablation of Barrett's Esophagus with High Grade Dysplasia
    Chandra, Subhash
    Marino, Danielle
    Kaul, Vivek
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S188 - S189
  • [30] RISK OF DYSPLASIA AND ESOPHAGEAL ADENOCARCINOMA IN PATIENTS WITH INTESTINAL METAPLASIA < 1 CM IN COMPARISON TO BARRETT'S ESOPHAGUS 1-2 CM IN LENGTH
    Freedman, Benjamin L.
    Bilal, Mohammad
    Kandasamy, Cinthana
    Singh, Shailendra
    Agnihotri, Abhishek
    Kumar, Manoj
    Horton, Laura C.
    Miller, Corey S.
    Chan, Brian P.
    Gonzalez, Raul S.
    Cohen, Jonah
    Sawhney, Mandeep
    Berzin, Tyler M.
    Pleskow, Douglas K.
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB394 - AB395